{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:09:44Z","timestamp":1791421784272,"version":"4.3.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T00:00:00Z","timestamp":1307923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T00:00:00Z","timestamp":1307923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/cmi.2011.16","type":"journal-article","created":{"date-parts":[[2011,6,13]],"date-time":"2011-06-13T08:44:06Z","timestamp":1307954646000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Anti-\u03b3\u03b4 TCR antibody-expanded \u03b3\u03b4 T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies"],"prefix":"10.1038","volume":"9","author":[{"given":"Jianhua","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denian","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,13]]},"reference":[{"key":"BFcmi201116_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1358\/dnp.2010.23.4.1439500","volume":"23","author":"HM Long","year":"2010","unstructured":"Long HM, Parsonage G, Fox CP, Lee SP . Immunotherapy for Epstein\u2013Barr virus-associated malignancies. Drug News Perspect 2010; 23: 221\u2013228.","journal-title":"Drug News Perspect"},{"key":"BFcmi201116_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","volume":"21","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD . The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004; 21: 137\u2013148.","journal-title":"Immunity"},{"key":"BFcmi201116_CR3","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.4049\/jimmunol.167.9.5092","volume":"167","author":"Y Kato","year":"2001","unstructured":"Kato Y, Tanaka Y, Miyagawa F, Yamashita S, Minato N . Targeting of tumor cells for human \u03b3\u03b4 T cells by nonpeptide antigens. J Immunol 2001; 167: 5092\u20135098.","journal-title":"J Immunol"},{"key":"BFcmi201116_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2781","volume":"10","author":"M Bonneville","year":"2010","unstructured":"Bonneville M, O'Brien RL, Born WK . Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10: 467\u2013478.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201116_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJM199903043400914","volume":"340","author":"V Kunzmann","year":"1999","unstructured":"Kunzmann V, Bauer E, Wilhelm M . \u03b3\/\u03b4 T-cell stimulation by pamidronate. N Engl J Med 1999; 340: 737\u2013738.","journal-title":"N Engl J Med"},{"key":"BFcmi201116_CR6","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00262-010-0879-0","volume":"59","author":"J Bennouna","year":"2010","unstructured":"Bennouna J, Levy V, Sicard H, Senellart H, Audrain M, Hiret S et al. Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors. Cancer Immunol Immunother 2010; 59: 1521\u20131530.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcmi201116_CR7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2249.2010.04167.x","volume":"161","author":"S Meraviglia","year":"2010","unstructured":"Meraviglia S, Eberl M, Vermijlen D, Todaro M, Buccheri S, Cicero G et al. In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol 2010; 161: 290\u2013297.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi201116_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00262-006-0199-6","volume":"56","author":"H Kobayashi","year":"2007","unstructured":"Kobayashi H, Tanaka Y, Yagi J, Osaka Y, Nakazawa H, Uchiyama T et al. Safety profile and antitumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study. Cancer Immunol Immunother 2007; 56: 469\u2013476.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcmi201116_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/14653249.2010.515581","volume":"13","author":"A Noguchi","year":"2011","unstructured":"Noguchi A, Kaneko T, Kamigaki T, Fujimoto K, Ozawa M, Saito M et al. Zoledronate-activated V\u03b39\u03b3\u03b4 T cell-based immunotherapy is feasible and restores the impairment of \u03b3\u03b4 T cells in patients with solid tumors. Cytotherapy 2011; 13: 92\u201397.","journal-title":"Cytotherapy"},{"key":"BFcmi201116_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/CJI.0b013e318207ecfb","volume":"34","author":"M Sakamoto","year":"2011","unstructured":"Sakamoto M, Nakajima J, Murakawa T, Fukami T, Yoshida Y, Murayama T et al. Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded \u03b3\u03b4T cells: a phase I clinical study. J Immunother 2011; 34: 202\u2013211.","journal-title":"J Immunother"},{"key":"BFcmi201116_CR11","first-page":"575","volume":"30","author":"H Kobayashi","year":"2010","unstructured":"Kobayashi H, Tanaka Y, Shimmura H, Minato N, Tanabe K . Complete remission of lung metastasis following adoptive immunotherapy using activated autologous gammadelta T-cells in a patient with renal cell carcinoma. Anticancer Res 2010; 30: 575\u2013579.","journal-title":"Anticancer Res"},{"key":"BFcmi201116_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-3083.2003.01288.x","volume":"58","author":"J Qi","year":"2003","unstructured":"Qi J, Zhang J, Zhang S, Cui L, He W . Immobilized MICA could expand human Vdelta1 gammadelta T cells in vitro that displayed major histocompatibility complex class I chain-related A-dependent cytotoxicity to human epithelial carcinomas. Scand J Immunol 2003; 58: 211\u2013220.","journal-title":"Scand J Immunol"},{"key":"BFcmi201116_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/0008-5472.CAN-06-3069","volume":"67","author":"D Kabelitz","year":"2007","unstructured":"Kabelitz D, Wesch D, He W . Perspectives of gammadelta T cells in tumor immunology Cancer Res 2007; 67: 5\u20138.","journal-title":"Cancer Res"},{"key":"BFcmi201116_CR14","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1073\/pnas.96.12.6879","volume":"96","author":"V Groh","year":"1999","unstructured":"Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T . Broad tumor-associated expression and recognition by tumor-derived \u03b3\u03b4 T cells of MIC-A and MIC-B. Proc Natl Acad Sci USA 1999; 96: 6879\u20136884.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201116_CR15","doi-asserted-by":"publisher","first-page":"9172","DOI":"10.1158\/0008-5472.CAN-04-2417","volume":"64","author":"A Poggi","year":"2004","unstructured":"Poggi A, Venturino C, Catellani S, Clavio M, Miglino M, Gobbi M et al. V\u03b41 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. Cancer Res 2004; 64: 9172\u20139179.","journal-title":"Cancer Res"},{"key":"BFcmi201116_CR16","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.4161\/cbt.8.16.8950","volume":"8","author":"N Kang","year":"2009","unstructured":"Kang N, Zhou J, Zhang T, Wang L, Lu F, Cui Y et al. Adoptive immunotherapy of lung cancer with immobilized anti-TCRgammadelta antibody-expanded human gammadelta T-cells in peripheral blood. Cancer Biol Ther 2009; 8: 1540\u20131549.","journal-title":"Cancer Biol Ther"},{"key":"BFcmi201116_CR17","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1084\/jem.183.4.1681","volume":"183","author":"MJ Maeurer","year":"1996","unstructured":"Maeurer MJ, Martin D, Walter W, Liu K, Zitvogel L, Halusczcak K et al. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med 1996; 183: 1681\u20131696.","journal-title":"J Exp Med"},{"key":"BFcmi201116_CR18","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T","volume":"31","author":"G Sireci","year":"2001","unstructured":"Sireci G, Espinosa E, Di Sano C, Dieli F, Fourni\u00e9 JJ, Salerno A . Differential activation of human gammadelta cells by nonpeptide phosphoantigens. Eur J Immunol 2001; 31: 1628\u20131635.","journal-title":"Eur J Immunol"},{"key":"BFcmi201116_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbrc.2005.10.198","volume":"339","author":"J Zhao","year":"2006","unstructured":"Zhao J, Huang J, Chen H, Cui L, He W . Vdelta1 T cell receptor binds specifically to MHC I chain related A: molecular and biochemical evidences. Biochem Biophys Res Commun 2006; 339: 232\u2013240.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcmi201116_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/intimm\/dxn057","volume":"20","author":"W Cao","year":"2008","unstructured":"Cao W, Xi X, Wang Z, Dong L, Hao Z, Cui L et al. Four novel ULBP splice variants are ligands for human NKG2D. Int Immunol 2008; 20: 981\u2013991.","journal-title":"Int Immunol"},{"key":"BFcmi201116_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.immuni.2004.11.012","volume":"22","author":"E Scotet","year":"2005","unstructured":"Scotet E, Martinez LO, Grant E, Barbaras R, Jen\u00f6 P, Guiraud M et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A\u2013I. Immunity 2005; 22: 71\u201380.","journal-title":"Immunity"},{"key":"BFcmi201116_CR22","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1182\/blood-2009-07-234211","volume":"116","author":"A Maniar","year":"2010","unstructured":"Maniar A, Zhang X, Lin W, Gastman BR, Pauza CD, Strome SE et al. Human \u03b3\u03b4 T lymphocytes induce robust NK cell mediated antitumor cytotoxicity through CD137 engagement. Blood 2010; 116: 1726\u20131733.","journal-title":"Blood"},{"key":"BFcmi201116_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1196\/annals.1358.011","volume":"1062","author":"N Shrestha","year":"2005","unstructured":"Shrestha N, Ida JA, Lubinski AS, Pallin M, Kaplan G, Haslett PA . Regulation of acquired immunity by gamma delta T-cell\/dendritic-cell interactions. Ann NY Acad Sci 2005; 1062: 79\u201394.","journal-title":"Ann NY Acad Sci"},{"key":"BFcmi201116_CR24","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.0810059106","volume":"106","author":"M Brandes","year":"2009","unstructured":"Brandes M, Willimann K, Bioley G, L\u00e9vy N, Eberl M, Luo M et al. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci USA 2009; 106: 2307\u20132312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201116_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/0008-5472.CAN-03-1501","volume":"64","author":"F Lozupone","year":"2004","unstructured":"Lozupone F, Pende D, Burgio VL, Castelli C, Spada M, Venditti M et al. Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice. Cancer Res 2004; 64: 378\u2013385.","journal-title":"Cancer Res"},{"key":"BFcmi201116_CR26","doi-asserted-by":"publisher","first-page":"6767","DOI":"10.4049\/jimmunol.173.11.6767","volume":"173","author":"D Kabelitz","year":"2004","unstructured":"Kabelitz D, Wesch D, Pitters E, Z\u00f6ller M . Characterization of tumor reactivity of human Vgamma9Vdelta2 gammadelta T cells in vitro and in SCID mice in vivo. J Immunol 2004; 173: 6767\u20136776.","journal-title":"J Immunol"},{"key":"BFcmi201116_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1084\/jem.20021500","volume":"197","author":"HJ Gober","year":"2003","unstructured":"Gober HJ, Kistowska M, Angman L, Jeno P, Mori L, de Libero G . Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003; 197: 163\u2013168.","journal-title":"J Exp Med"},{"key":"BFcmi201116_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","volume":"13","author":"H Ikeda","year":"2002","unstructured":"Ikeda H, Old LJ, Schreiber RD . The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002; 13: 95\u2013109.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFcmi201116_CR29","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1182\/blood-2004-01-0331","volume":"104","author":"DF Angelini","year":"2004","unstructured":"Angelini DF, Borsellino G, Poupot M, Diamantini A, Poupot R, Bernardi G et al. Fc\u03b3RIII discriminates between 2 subsets of V\u03b39V\u03b42 effector cells with different responses and activation pathways. Blood 2004; 104: 1801\u20131807.","journal-title":"Blood"},{"key":"BFcmi201116_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1084\/jem.20030235","volume":"198","author":"F Dieli","year":"2003","unstructured":"Dieli F, Poccia F, Lipp M, Sireci G, Caccamo N, Di Sano C et al. Differentiation of effector\/memory V\u03b42 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med 2003; 198: 391\u2013397.","journal-title":"J Exp Med"},{"key":"BFcmi201116_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4049\/jimmunol.177.2.877","volume":"177","author":"Y Kato","year":"2006","unstructured":"Kato Y, Tanaka Y, Hayashi M, Okawa K, Minato N . Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens. J Immunol 2006; 177: 877\u2013884.","journal-title":"J Immunol"},{"key":"BFcmi201116_CR32","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1182\/blood-2007-09-112128","volume":"111","author":"Y Ma","year":"2008","unstructured":"Ma Y, Visser L, Roelofsen H, de Vries M, Diepstra A, van Imhoff G et al. Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 2008; 111: 2339\u20132346.","journal-title":"Blood"},{"key":"BFcmi201116_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1084\/jem.174.4.949","volume":"174","author":"A Aruffo","year":"1991","unstructured":"Aruffo A, Melnick MB, Linsley PS, Seed B . The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J Exp Med 1991; 174: 949\u2013952.","journal-title":"J Exp Med"},{"key":"BFcmi201116_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0167-5699(97)01130-4","volume":"18","author":"A Aruffo","year":"1997","unstructured":"Aruffo A, Bowen MA, Patel DD, Haynes BF, Starling GC, Gebe JA et al. CD6-ligand interactions: a paradigm for SRCR domain function? Immunol Today 1997; 18: 498\u2013504.","journal-title":"Immunol Today"},{"key":"BFcmi201116_CR35","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1182\/blood-2009-08-237123","volume":"115","author":"T Lan\u00e7a","year":"2010","unstructured":"Lan\u00e7a T, Correia DV, Moita CF, Raquel H, Neves-Costa A, Ferreira C et al. The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia\/lymphoma susceptibility to \u03b3\u03b4 T-cell cytotoxicity. Blood 2010; 115: 2407\u20132411.","journal-title":"Blood"},{"key":"BFcmi201116_CR36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","volume":"8","author":"Y Agata","year":"1996","unstructured":"Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8: 765\u2013772.","journal-title":"Int Immunol"},{"key":"BFcmi201116_CR37","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB et al. Tumor associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002; 8: 793\u2013800.","journal-title":"Nat Med"},{"key":"BFcmi201116_CR38","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1182\/blood-2007-05-085159","volume":"111","author":"R Yamamoto","year":"2008","unstructured":"Yamamoto R, Nishikori M, Kitawaki T, Sakai T, Hishizawa M, Tashima M et al. PD-1\u2013PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 2008; 111: 3220\u20133224.","journal-title":"Blood"},{"key":"BFcmi201116_CR39","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.1089.65.3","volume":"65","author":"F Hirano","year":"2005","unstructured":"Hirano F, Kaneko K, Tamura H, Dong H, Wang S, Ichikawa M et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 2005; 65: 1089\u20131096.","journal-title":"Cancer Res"},{"key":"BFcmi201116_CR40","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1182\/blood-2006-06-028985","volume":"109","author":"S Catellani","year":"2007","unstructured":"Catellani S, Poggi A, Bruzzone A, Dadati P, Ravetti JL, Gobbi M et al. Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins. Blood 2007; 109: 2078\u20132085.","journal-title":"Blood"},{"key":"BFcmi201116_CR41","doi-asserted-by":"crossref","unstructured":"Siegers GM, Dhamko H, Wang XH, Mathieson AM, Kosaka Y, Felizardo TC et al. Human V\u03b41 \u03b3\u03b4 T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells. Cytotherapy 2011; 11: in press.","DOI":"10.3109\/14653249.2011.553595"},{"key":"BFcmi201116_CR42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2010.05.005","volume":"297","author":"P Dokouhaki","year":"2010","unstructured":"Dokouhaki P, Han M, Joe B, Li M, Johnston MR, Tsao MS et al. Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: a new approach. Cancer Lett 2010; 297: 126\u2013136.","journal-title":"Cancer Lett"},{"key":"BFcmi201116_CR43","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s00262-006-0133-y","volume":"55","author":"T Nakanishi","year":"2006","unstructured":"Nakanishi T, Imaizumi K, Hasegawa Y, Kawabe T, Hashimoto N, Okamoto M et al. Expression of macrophage-derived chemokine (MDC)\/CCL22 in human lung cancer. Cancer Immunol Immunother 2006; 55: 1320\u20131329.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcmi201116_CR44","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/ijc.23392","volume":"122","author":"Y Mizukami","year":"2008","unstructured":"Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H et al. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Int J Cancer 2008; 122: 2286\u20132293.","journal-title":"Int J Cancer"},{"key":"BFcmi201116_CR45","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","volume":"107","author":"ZZ Yang","year":"2006","unstructured":"Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM . Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 2006; 107: 3639\u20133646.","journal-title":"Blood"},{"key":"BFcmi201116_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/00000478-200107000-00011","volume":"25","author":"SC Peh","year":"2001","unstructured":"Peh SC, Kim LH, Poppema S . TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol 2001; 25: 925\u2013929.","journal-title":"Am J Surg Pathol"},{"key":"BFcmi201116_CR47","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.leukres.2008.02.016","volume":"32","author":"C Thielen","year":"2008","unstructured":"Thielen C, Radermacher V, Trimeche M, Roufosse F, Goldman M, Boniver J et al. TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk Res 2008; 32: 1431\u20131438.","journal-title":"Leuk Res"},{"key":"BFcmi201116_CR48","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0002-9440(10)65424-7","volume":"154","author":"A van den Berg","year":"1999","unstructured":"van den Berg A, Visser L, Poppema S . High expression of the CC chemokine TARC in Reed\u2013Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 1999; 154: 1685\u20131691.","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"BFcmi201116_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/annonc\/13.S1.52","volume":"13","author":"E Maggio","year":"2002","unstructured":"Maggio E, van den Berg A, Diepstra A, Kluiver J, Visser L, Poppema S . Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues. Ann Oncol 2002; 13 ( Suppl 1): 52\u201356.","journal-title":"Ann Oncol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T10:26:11Z","timestamp":1672741571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,13]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFcmi201116"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2011.16","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,13]]},"assertion":[{"value":"16 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}